Assignee
ENLITISA SHANGHAI PHARMACEUTICAL CO LTD
CN·3 granted patents·9 pending applications·1 citations·filing 2018–2024
Top patents by PatentIndex Score
12 records- 0178US2025302818A1Topical formulations comprising montelukast and combinations with mussel adhesive proteinsENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0273US11672792B2Topical formulations comprising montelukast and combinations with mussel adhesive proteinsENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Jun 13, 2023·1 cites·19 claims
- 0373US2023404992A1Topical formulations comprising montelukast and combinations with mussel adhesive proteinsENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0472US2025041377A1Pharmaceutical useENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0569US2023348536A1Conjugates of montelukast and peptidesENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0667US2023113836A1New conjugates of peptides and polysaccharideENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 0766US12129313B2Anti-inflammatory use of peptideENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Oct 29, 2024·0 cites·14 claims
- 0864US11680082B2Conjugates of montelukast and peptidesENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Jun 20, 2023·0 cites·40 claims
- 0956US2024316029A1New treatment of immunodeficiency disorderENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1055US2025066417A9New peptide-based diagnostic and therapeutic agentsENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1151US2023331792A1New multi-functional oligopeptidesENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1250US2024124521A1New peptidesENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ENLITISA SHANGHAI PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →